Recent Multiple Sclerosis (MS) Research for November 2024
Europe Multiple Sclerosis Therapeutics Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Drug Class (Immunosuppressant and Immunomodulators), Route of Administration (Injectable and Oral), and Distribution Channel (Hospital Pharmacies, Re
Topics: Multiple Sclerosis (MS), COVID-19/Coronavirus, Hospitals & Clinics, Needles, Syringes, IV Access, Pharmacy & Distribution, Drug Discovery, Drug Stores
Regions: Europe
| Middle East and Africa Multiple Sclerosis Therapeutics Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Drug Class (Immunosuppressant and Immunomodulators), Route of Administration (Injectable and Oral), and Distribution Channel (Hospita
Topics: Multiple Sclerosis (MS), COVID-19/Coronavirus, Hospitals & Clinics, Needles, Syringes, IV Access, Pharmacy & Distribution, Drug Discovery, Drug Stores
Regions: Middle East
| North America Multiple Sclerosis Therapeutics Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Drug Class (Immunosuppressant and Immunomodulators), Route of Administration (Injectable and Oral), and Distribution Channel (Hospital Pharmac
Topics: Multiple Sclerosis (MS), COVID-19/Coronavirus, Hospitals & Clinics, Needles, Syringes, IV Access, Drug Discovery, Drug Stores
Regions: North America
| Blood Brain Barrier Technologies Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Technology (Bispecific Antibody RMT Approach, Trojan Horse Approach, Increasing Permeability, Passive Diffusion, and Other Non-Invasive BBB Technologies); Ap
Topics: Alzheimer's Disease, Cancer Treatment, Parkinson's Disease, Multiple Sclerosis (MS), Epilepsy, COVID-19/Coronavirus
Regions: Global
| Secondary Progressive Multiple Sclerosis (SPMS) - Market Insight, Epidemiology and Market Forecast -2032
Topics: Multiple Sclerosis (MS), Drug Discovery
| Multiple Sclerosis Market Insight, Epidemiology and Market Forecast -2032
Topics: Multiple Sclerosis (MS), Drug Discovery
| Global Multiple Sclerosis Therapeutics Market- 2020-2027
Topics: Multiple Sclerosis (MS), Drug Discovery
Regions: Global
| Global Central Nervous System Therapeutics Market, By Drug Class (Multiple Sclerosis, Antipsychotic, Antiepileptics, Analgesics & Anesthetics, Anti-Parkinson, Others), By Application (Neurodegenerative Diseases, Mental Health and Trauma, Neurovascular Dis
Topics: Cancer Treatment, Mental Health, Parkinson's Disease, Multiple Sclerosis (MS), Hospitals & Clinics, Pharmacy & Distribution, Drug Discovery, Clinical Nutrition, Drug Stores, Infectious Diseases, CNS/Neurology
Regions: Global
| Neurological Biomarkers Market, by Biomarker Type (Imaging Biomarkers, Metabolomics Biomarkers, Proteomic Biomarkers, and Genomics Biomarkers), by Application (Alzheimer’s Disease, Parkinson’s Disease, Multiple Sclerosis, Autism Spectrum Disorders, and Ot
Topics: Genomics, Proteomics, Biomarkers, Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis (MS), Hospitals & Clinics, CNS/Neurology
Regions: Asia, Europe, Middle East, North America, Oceania
| Interferons Global Market Report 2021: COVID 19 Implications And Growth to 2030
Topics: Research & Development, Drug Development, Hepatitis, Multiple Sclerosis (MS), COVID-19/Coronavirus
Regions: Global
| Multiple Sclerosis Disease - Global Clinical Trials Review, H1, 2021
Topics: Multiple Sclerosis (MS), Clinical Trial
Regions: Global
| Global Multiple Sclerosis Market and Competitive Landscape – 2017
Topics: Multiple Sclerosis (MS)
Regions: Global
|
Prev | 1 | 2 | Next
About MarketResearch.com
MarketResearch.com is an online aggregator selling over 400,000 market research reports, company profiles and country profiles from over 350 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.
|
